Latest Breaking News On - Daniel faga - Page 1 : comparemela.com

Anaptys Taps $50M From Sagard Deal - San Diego Business Journal

Anaptys Taps $50M From Sagard Deal - San Diego Business Journal
sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.

San-diego
California
United-states
Ali-alagheband
Daniel-faga
Nasdaq
Anaptysbio-inc
Sagard-healthcare
Anaptys-discovered-jemperli
Anaptysbio-president

Wedbush Comments on AnaptysBio, Inc.'s Q1 2025 Earnings (NASDAQ:ANAB)

Wedbush Comments on AnaptysBio, Inc.'s Q1 2025 Earnings (NASDAQ:ANAB)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Ericj-loumeau
Leerink-partnrs
Daniel-faga
Stifel-nicolaus
Anaptysbio-inc
First-light-asset-management
Great-point-partners
Nasdaq
Securities-exchange-commission
Jpmorgan-chase-co
Franklin-resources-inc
Eventide-asset-management

AnaptysBio (NASDAQ:ANAB) Earns Outperform Rating from Wedbush

AnaptysBio (NASDAQ:ANAB) Earns Outperform Rating from Wedbush
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China
Daniel-faga
Leerink-partnrs
Piper-sandler
Zurcher-kantonalbank-zurich-cantonalbank
Ericj-loumeau
Stifel-nicolaus
China-universal-asset-management-co
Quest-partners
Anaptysbio-inc
Securities-exchange-commission
Sg-americas-securities

Studies Show Imsidolimab Effective for Generalized Pustular Psoriasis

Studies Show Imsidolimab Effective for Generalized Pustular Psoriasis
empr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from empr.com Daily Mail and Mail on Sunday newspapers.

Daniel-faga
Global-assessment

Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)

Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Nick-montemarano
Daniel-faga
Paul-lizzul
Linkedin
Nasdaq
Exchange-commission
Strategic-communications
Drug-administration
Anaptysbio-inc
Global-assessment
Well-tolerated-through-end
Drug-reaction